Robotic Surgery CEO Writes $498K With a Cross About to Trigger

ISB Research · Interesting · sent to Ultimate members August 10, 2026

Larry Wood runs PROCEPT BioRobotics, the surgical robotics outfit going after prostate surgery, and this is his first buy on the ticker at $20.85. Price sits just above the 8-day and the 8 is squeezing up toward the 20. When that cross fires, systematic buyers tend to show up, and Wood's already positioned. The short-term trend agrees, but the medium and long timeframes still read sell, so respect the resistance at $24.20 and the risk that this stalls. A bull put spread beneath his $20.85 buy price lets you get paid to wait for an entry underneath the guy who knows the business best.

Ultimate members received this analysis in real time.